Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patients-Reference-Cited by-同舟云学术

Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patients

Published:2013-06 Issue:6 Volume:58 Page:1089-1095
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Martinot-Peignoux Michelle,Carvalho-Filho Roberto,Lapalus Martine,Netto-Cardoso Ana Carolina Ferreira,Lada Olivier,Batrla Richard,Krause Friedemann,Asselah Tarik,Marcellin Patrick

Funder

Roche Diagnostics

Publisher

Elsevier BV

Subject

Hepatology

Reference25 articles.

1. Virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures;Lavanchy;J Viral Hepat,2004

2. Hepatitis B infection;Liaw;Lancet,2009

3. Centers for disease control and prevention. Surveillance for acute viral hepatitis – United States, 2006;Wasley;MMWR Surveill Summ,2008

4. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DVA level;Chen;JAMA,2006

5. High viral load and hepatitis B virus subgenotype Ce are associated with increased risk of hepatocellular carcinoma;Chan;J Clin Oncol,2010

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation between quantitative HBsAg and quantitative HBV DNA in chronic hepatitis B patients: a systematic review and meta-analysis;Egyptian Liver Journal;2024-05-21

2. Letter: Association of persistently high HBsAg levels during HBeAg‐seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients—Authors' reply;Alimentary Pharmacology & Therapeutics;2024-04-25

3. Albumin-bilirubin score as a predictor of all-cause mortality in patients with hepatitis B virus infection: An analysis of National Health and Nutrition Examination Survey (NHANES) 1999–2018;Preventive Medicine Reports;2024-03

4. Can quantitative surface antigen levels and systemic immune-inflammation index be predictive as a new indicator for the initiation of treatment in chronic hepatitis b?;European Journal of Gastroenterology & Hepatology;2024-02-16

5. The performance of hepatitis B surface antigen quantification as a noninvasive biomarker predicting liver injury and serum hepatitis B virus DNA level;European Journal of Gastroenterology & Hepatology;2023-12-11